Pharmaceutical company Merck will invest $1 billion to build a 470,000 square-foot facility in Wilmington, Delaware, in a bid to boost domestic production, the company said in an April 29 statement.
The facility, located at the Chestnut Run Innovation & Science Park, is expected to create “more than 500 full-time roles and roughly 4,000 construction jobs,” the company said.
“The laboratory component is expected to be fully operational by 2028, with production of investigational compounds anticipated to start by 2030. Potential further expansion of the site would create an additional 1,500 full-time roles and 26,000 construction jobs,” it said.
The facility will comprise laboratory, manufacturing, and warehouse capabilities to aid the launch and commercial production of Merck’s medical offerings….